Japan's Takeda says CEO Weber to step down, raises profit forecast
Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after 12 years in management at Japan's biggest ...
Takeda Prevails Over Sales Rep's Race, Disability Bias Claims
Takeda Pharmaceuticals America Inc. convinced a federal court to toss an employee’s claims that the company discriminated against her for being a White woman with depression and PTSD.
Takeda Pharmaceutical Company Limited (TAK) Q3 2025 Earnings Call Transcript
Q3 2025 Results Conference Call January 30, 2025 5:30 AM ET. Company Participants. Christopher O’Reilly - Head, Investor Relatio ...
devdiscourse11h
Zydus Takeda's Vashi Plant Celebrates 25 Years of Excellence
Zydus Takeda Healthcare Private Limited, a joint venture between Zydus Lifesciences and Takeda Pharmaceutical, celebrates the ...
ジャパンタイムズ13h
Takeda picks first female CEO of centuries-old drugmaker
Julie Kim, 54, has been running Takeda’s U.S. operations since 2022 and will assume the role of CEO in June next year, ...
Takeda gains after FY24 guidance raise, CEO transition
Takeda (TAK) stock rose in premarket trading after raising its full-year outlook and appointing Julie Kim as the next CEO.
Nikkei Asia8h
Japan's Takeda names 1st female CEO in leadership change
TOKYO -- Japan's Takeda Pharmaceutical announced on Thursday that CEO Christophe Weber will step down in June 2026 and be succeeded by current U.S. business head Julie Kim, who would become the ...
Japan's Takeda says Q3 profit slid 38%, trailing analyst estimates
Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates, as ...